<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04364854</url>
  </required_header>
  <id_info>
    <org_study_id>00091924</org_study_id>
    <secondary_id>U01DC017521-01A1</secondary_id>
    <nct_id>NCT04364854</nct_id>
  </id_info>
  <brief_title>Speech Entrainment for Aphasia Recovery</brief_title>
  <acronym>SpARc</acronym>
  <official_title>Speech Entrainment for Aphasia Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Deafness and Other Communication Disorders (NIDCD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After a stroke, many people experience a language impairment called aphasia. One of the most
      debilitating types of aphasia is non-fluent aphasia. Non-fluent aphasia is defined by
      significantly reduced speech production, with the speaker producing only a few words or even
      less. Speech entrainment therapy (SET) is a treatment that has been shown to increase fluency
      in people with non-fluent aphasia. The study looks to define the best dose of SET that leads
      to sustained improvements in spontaneous speech production.

      Participants who are eligible will undergo baseline language testing, an MRI, and will be
      randomized into one of 4 treatment groups: SET for 3 weeks, SET for 4.5 weeks, SET for 6
      weeks, and no treatment (control group).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2025</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Verbs Per Minute (VPM) in Speech Sample</measure>
    <time_frame>3 months after treatment (or no treatment)</time_frame>
    <description>VPM will be assessed through procedural storytelling and narrative story telling tasks - with four items in each category. The procedural storytelling items are: 1) how to make a peanut butter and jelly sandwich, 2) how to make scrambled eggs, 3) how to brew coffee, and 4) how to wash dishes.
The narrative items will be: 1) Cinderella story, 2) Little Red Riding Hood, 3) The Three Little Pigs, and 4) Goldilocks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)</measure>
    <time_frame>3 months after treatment (or no treatment)</time_frame>
    <description>We will estimate the dose of SET for individuals with non-fluent aphasia that has the highest effect size on SAQOL-39g.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Aphasia</condition>
  <condition>Aphasia Non Fluent</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>SET (Speech Entrainment Therapy) 3 weeks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SET (Speech Entrainment Therapy) 4.5 weeks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>SET (Speech Entrainment Therapy) 6 weeks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No Therapy 6 weeks</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SET (Speech Entrainment Therapy) 3 weeks</intervention_name>
    <description>3 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program</description>
    <arm_group_label>SET (Speech Entrainment Therapy) 3 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SET (Speech Entrainment Therapy) 4.5 weeks</intervention_name>
    <description>4.5 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program</description>
    <arm_group_label>SET (Speech Entrainment Therapy) 4.5 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SET (Speech Entrainment Therapy) 6 weeks</intervention_name>
    <description>6 weeks of SET which consists of practicing fluent speech in real time with an audio-visual computer program</description>
    <arm_group_label>SET (Speech Entrainment Therapy) 6 weeks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Therapy 6 Weeks</intervention_name>
    <description>Participants will not be getting any SET for 6 weeks</description>
    <arm_group_label>No Therapy 6 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Aphasia as a result of a left hemisphere ischemic or hemorrhagic stroke (WAB-R Aphasia
             quotient &lt;93.8).

          -  Patients must have spoken English as their primary language.

          -  21-81 years old

          -  pre-stroke modified Rankin Scale (mRS)= 2 or less,

          -  post-stroke mRS= 4 or less.

          -  At least 6 months post-stroke.

          -  Non-fluent aphasia (WAB-R comprehension score &gt;4 and WAB-R fluency score &lt;6).

        Exclusion Criteria

          -  History of chronic neurological or psychiatric diseases (excluding migraines,
             depression, or post-stroke epilepsy). Self-reported history of learning disability.

          -  Severe dysarthria.

          -  History of right hemisphere strokes or brain stem/cerebellar strokes (As evidenced by
             MRI or CT).

          -  Uncorrectable hearing or vision.

          -  Contraindications to MRI or inability to complete the MRI scanning session.

          -  Women who are pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>81 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonardo Bonilha, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Doyle, MS, CCC-SLP</last_name>
    <phone>843-792-3678</phone>
    <email>doylean@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kelly Krajeck, MHA</last_name>
    <phone>843-792-4088</phone>
    <email>krajeck@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna C Doyle, MS</last_name>
      <phone>843-792-3678</phone>
      <email>doylean@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Leonardo Bonilha, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Carolina</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Aitchison, PhD</last_name>
      <phone>803-777-5905</phone>
      <email>mjaitchi@mailbox.sc.edu</email>
    </contact>
    <investigator>
      <last_name>Julius Fridriksson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Wambaugh, PhD</last_name>
      <phone>801-585-6164</phone>
      <email>julie.wambaugh@health.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Kraemer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Wambaugh, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 23, 2020</study_first_submitted>
  <study_first_submitted_qc>April 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Leonardo Bonilha</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Aphasia</keyword>
  <keyword>Speech Language Pathology</keyword>
  <keyword>Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aphasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

